{"gene":"TSC1","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1997,"finding":"TSC1 encodes a 130 kDa protein (hamartin) that acts as a tumor suppressor; somatic mutation of the wild-type allele was found in a TSC-associated renal carcinoma, consistent with a two-hit tumor suppressor model.","method":"Positional cloning, mutation analysis, loss-of-heterozygosity analysis in tumor tissue","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — original gene identification with direct molecular evidence (somatic LOH in tumor), widely replicated","pmids":["9242607"],"is_preprint":false},{"year":1998,"finding":"Hamartin (TSC1) and tuberin (TSC2) physically associate in vivo, and this interaction is mediated by predicted coiled-coil domains in both proteins, indicating they function together in the same complex.","method":"Co-immunoprecipitation, yeast two-hybrid, domain mapping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP at endogenous levels, replicated by multiple independent labs","pmids":["9580671"],"is_preprint":false},{"year":1998,"finding":"Hamartin localizes to the membrane/particulate (P100) fraction of cells and displays a punctate cytoplasmic immunofluorescence pattern consistent with cytoplasmic vesicles; this localization is independent of tuberin.","method":"Subcellular fractionation, immunofluorescence microscopy","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — fractionation and IF from a single lab, replicated in Eker rat cells lacking tuberin","pmids":["9809973"],"is_preprint":false},{"year":2000,"finding":"Hamartin interacts with the ezrin-radixin-moesin (ERM) family of actin-binding proteins; overexpression of hamartin activates the small GTPase Rho, induces actin stress fiber assembly and focal adhesion formation, whereas inhibition of hamartin causes loss of adhesion. Endogenous hamartin-ERM interaction is required for Rho activation by serum or LPA.","method":"Co-immunoprecipitation, dominant-negative inhibition, overexpression, Rho activity assays, actin/focal adhesion staining","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, functional assays, dominant-negative), single lab with rigorous controls","pmids":["10806479"],"is_preprint":false},{"year":2000,"finding":"Hamartin stabilizes tuberin by binding to it and preventing its ubiquitination; the fraction of tuberin bound to hamartin is not ubiquitinated, whereas unbound tuberin is highly ubiquitinated and degraded. Co-expression of tuberin also stabilizes hamartin.","method":"Co-transfection, immunoprecipitation, ubiquitination assay, pulse-chase","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct biochemical demonstration of ubiquitination protection, multiple constructs and mutants tested","pmids":["11175345"],"is_preprint":false},{"year":2000,"finding":"Ectopic hamartin expression inhibits cell proliferation and arrests cells in G1 phase; this growth-inhibitory effect depends on the coiled-coil domain implicated in tuberin binding.","method":"Overexpression, cell proliferation assay, cell cycle analysis, domain-deletion constructs","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional overexpression with domain mapping, single lab","pmids":["10915759"],"is_preprint":false},{"year":2001,"finding":"Hamartin (amino acids 302–430) and tuberin (amino acids 1–418, requiring a coiled-coil region at 346–371 plus additional N-terminal residues) directly interact; TSC patient-derived pathological mutations within these binding regions abolish or dramatically reduce hamartin-tuberin interaction in yeast two-hybrid and co-IP assays.","method":"Yeast two-hybrid, co-immunoprecipitation, pathological mutation analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — two orthogonal binding assays, pathological vs. non-pathogenic mutant discrimination, single lab","pmids":["11741833"],"is_preprint":false},{"year":2001,"finding":"Tuberin phosphorylation at serine and tyrosine residues regulates its interaction with hamartin; disease-associated TSC2 mutations (Y1571H, P1675L) reduce tuberin phosphorylation, decrease TSC1-TSC2 interaction, and impair tuberin's growth-inhibitory function.","method":"Phosphorylation assays, co-immunoprecipitation, growth inhibition assays, patient-derived mutants","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct phosphorylation-interaction linkage with disease mutants, single lab","pmids":["11290735"],"is_preprint":false},{"year":2001,"finding":"Hamartin and tuberin interact with and co-localize with CDK1 (cdc2) and its regulatory partners cyclin B1 and cyclin A in multiple cell types, suggesting a direct role for both proteins in modulating CDK1 activity at the G2/M transition.","method":"Co-immunoprecipitation, confocal co-localization","journal":"Journal of neuropathology and experimental neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP/co-localization, single lab, no functional mechanistic follow-up","pmids":["11444800"],"is_preprint":false},{"year":2003,"finding":"The TSC1-TSC2 (hamartin-tuberin) heterodimer acts as a GTPase-activating protein (GAP) for the small GTPase Rheb in vitro; Rheb mediates nutrient/mTOR signaling upstream of mTOR and downstream of TSC1/TSC2. Patient-derived tuberin GAP domain mutants could not inactivate Rheb, placing TSC1/TSC2 as a GAP complex for Rheb to negatively regulate mTORC1.","method":"In vitro GAP assay, overexpression epistasis, S6K1 phosphorylation readout, rapamycin sensitivity, patient-derived mutants","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstituted GAP assay plus multiple cellular epistasis experiments; independently replicated","pmids":["12906785"],"is_preprint":false},{"year":2003,"finding":"The tuberin-hamartin complex co-immunoprecipitates with glycogen synthase kinase 3β (GSK3β) and Axin in a Wnt-1-dependent manner and negatively regulates β-catenin stability and TCF/LEF transcriptional activity by participating in the β-catenin degradation complex.","method":"Co-immunoprecipitation, luciferase reporter assay, β-catenin stability/half-life measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with multiple complex components, reporter assay, single lab","pmids":["12511557"],"is_preprint":false},{"year":2003,"finding":"Cyclin-dependent kinase 1 (CDK1)/cyclin B phosphorylates hamartin at Thr417 (within the hamartin-tuberin interaction domain) and two other sites during G2/M; phospho-hamartin still interacts with tuberin; alanine mutations at all three CDK1 sites increase the inhibitory activity of the hamartin-tuberin complex on p70S6K.","method":"In vitro kinase assay, cell-cycle synchronization, site-directed mutagenesis, S6K phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with mutagenesis and functional readout in cells, single lab","pmids":["14551205"],"is_preprint":false},{"year":2004,"finding":"TSC2 modulates actin dynamics and focal adhesion through the TSC1-binding domain (HBD); TSC2 expression promotes Rac1 activation and inhibits Rho, leading to stress fiber disassembly. TSC1 siRNA knockdown in TSC2-null cells activates Rac1, demonstrating that TSC1 inhibits Rac1 and TSC2 blocks this TSC1 activity.","method":"siRNA knockdown, Rac1/Rho activity assays, domain constructs, actin/focal adhesion staining","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and biochemical dissection in TSC2-null cells with domain constructs, single lab","pmids":["15611338"],"is_preprint":false},{"year":2005,"finding":"Hamartin localizes to the centrosome and interacts with polo-like kinase 1 (Plk1) in a phosphorylation-dependent manner; the interaction requires phosphorylation of Thr310 on hamartin. Hamartin negatively regulates Plk1 protein levels. Tsc1-null MEFs exhibit increased centrosome number and DNA content, rescued by rapamycin but not Plk1 RNAi.","method":"Immunofluorescence (centrosome localization), co-immunoprecipitation, site-directed mutagenesis (T310A), immunoblot, rapamycin rescue, RNAi","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with phospho-mutant, centrosome localization by IF, functional Tsc1-null MEF phenotype, single lab","pmids":["16339216"],"is_preprint":false},{"year":2005,"finding":"Cyclin D1 (and other D-type cyclins) negatively regulate TSC1-TSC2: coexpression of cyclin D1-CDK4/6 increases phosphorylation and decreases steady-state levels of both TSC2 and TSC1, and promotes phosphorylation of mTOR substrates 4E-BP1 and S6K1. Cyclin D1 also down-regulates TSC proteins independently of CDK4/6.","method":"Co-expression, immunoblot, mTOR substrate phosphorylation assay, CDK4/6-independent mutant cyclin D1","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple constructs and conditions tested, single lab, no direct kinase assay on TSC1","pmids":["16357142"],"is_preprint":false},{"year":2006,"finding":"TSC1 stabilizes TSC2 by excluding the HERC1 E3 ubiquitin ligase from the TSC2 complex; disease mutations in TSC2 that cause its destabilization allow HERC1 binding even in the presence of TSC1.","method":"Co-immunoprecipitation, ubiquitination assay, patient-derived TSC2 mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ubiquitination assay, mechanistic explanation via mutant analysis, single lab with multiple orthogonal approaches","pmids":["16464865"],"is_preprint":false},{"year":2006,"finding":"TSC1/TSC2 loss impairs NF-κB activation and cell survival after DNA damage or TNFα; rapamycin-mediated inhibition of deregulated mTOR activity in TSC2-null cells restores NF-κB activation and survival, identifying a crosstalk between the TSC/Rheb/mTOR and NF-κB pathways.","method":"TSC1/TSC2-deficient MEFs, NF-κB reporter assay, survival assay, rapamycin treatment, reconstitution","journal":"Cancer cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in null MEFs with pharmacological rescue, single lab","pmids":["16959613"],"is_preprint":false},{"year":2006,"finding":"TSC1/TSC2 have differential effects on mTORC1 and mTORC2: TSC1/TSC2 negatively regulates TORC1 and positively regulates TORC2 activity; Rheb activates TORC1 but inhibits TORC2 (via a feedback through TORC1/S6K).","method":"Genetic knockdown/overexpression in Drosophila S2 cells and HEK293 cells, S6K and Akt phosphorylation as TORC1/2 readouts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays in two cell systems, single lab","pmids":["16627617"],"is_preprint":false},{"year":2007,"finding":"IKKβ physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1 function and consequent mTOR pathway activation, enhanced angiogenesis, and tumor development.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, IHC in tumor samples, functional angiogenesis/tumor assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay identifying specific phosphorylation sites on TSC1, Co-IP, functional tumor phenotype, validated in human tumors","pmids":["17693255"],"is_preprint":false},{"year":2007,"finding":"TSC1 loss causes increased translation of nucleophosmin mRNA via mTOR activation, leading to greater nucleophosmin protein, enhanced nuclear export of ribosome subunits, higher overall rates of protein synthesis, and increased proliferation; TSC1 re-introduction suppresses nucleophosmin accumulation.","method":"Tsc1 genetic ablation, polysome profiling, ribosome export assay, TSC1 reconstitution, rapamycin treatment","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic ablation plus reconstitution with multiple readouts, single lab","pmids":["17308101"],"is_preprint":false},{"year":2008,"finding":"Zebrafish tsc1a morpholino knockdown causes ciliary phenotypes (kidney cysts, left-right asymmetry defects) and elongated cilia; tsc1a acts synthetically with ciliary genes; Tsc1a localizes to the Golgi; mTOR pathway is aberrantly activated in ciliary mutants resembling tsc1a knockdown; rapamycin blocks cyst formation in ciliary mutants.","method":"Morpholino knockdown, genetic interaction (synthetic lethality), immunofluorescence localization, rapamycin rescue","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — morpholino knockdown with genetic interaction and pharmacological rescue, zebrafish model, single lab","pmids":["19008302"],"is_preprint":false},{"year":2014,"finding":"TSC1 inhibits M1 macrophage polarization via a Ras GTPase-Raf1-MEK-ERK pathway independently of mTOR, and promotes M2 polarization via an mTOR-dependent C/EBPβ pathway; deletion of mTOR fails to reverse the enhanced M1 response of TSC1-deficient macrophages.","method":"Myeloid-specific TSC1 knockout mice, rapamycin treatment, mTOR deletion, ERK pathway analysis, cytokine assays, asthma model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional KO, pharmacological and genetic mTOR inhibition, identification of mTOR-independent ERK pathway, multiple orthogonal methods","pmids":["25175012"],"is_preprint":false},{"year":2015,"finding":"TSC1 functions independently of TSC2 as a component of the TGF-β-Smad2/3 pathway: TSC1 interacts with the TGF-β receptor complex and Smad2/3, is required for their association, and regulates TGF-β-induced Smad2/3 phosphorylation, target gene expression, growth arrest, and EMT. Hyperactive Akt activates TSC1-dependent cytostatic Smad signaling.","method":"Co-immunoprecipitation, Smad phosphorylation assay, gene expression (target genes), loss-of-function (TSC1 KD), EMT assay, Akt activation","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP with receptor complex and Smads, functional KD with multiple readouts (phosphorylation, transcription, EMT), TSC2-independent mechanism established, single lab with orthogonal methods","pmids":["25727005"],"is_preprint":false},{"year":2021,"finding":"TSC1 contains three structural domains: a C-terminal coiled-coil interacting with TSC2, a central helical domain mediating TSC1 oligomerization, and an N-terminal HEAT repeat domain that binds lysosomal phosphatidylinositol phosphates (PIPs), particularly PI3,5P2. Lysosomal recruitment of the TSC complex and subsequent mTORC1 inactivation upon starvation require TSC1 binding to PI3,5P2. TSC1 architecture and membrane binding are conserved from fungi to humans.","method":"Structural characterization (domain mapping), lipid-binding assay (PIP binding), lysosomal recruitment assay, mTORC1 activity assay under starvation, conservation analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural domain definition with functional lipid-binding and lysosomal recruitment assays plus mTORC1 functional readout, mechanistically rigorous","pmids":["33974911"],"is_preprint":false},{"year":2021,"finding":"TSC1, but not TSC2, migrates from the cytoplasm to junctional membranes when epithelial cells establish contact; at junctions, TSC1 binds myosin 6 to anchor the perijunctional actin cytoskeleton to β-catenin and ZO-1, enabling tight junction formation independent of mTORC1. Intestine- or skin-specific Tsc1 ablation disrupts tight/adherens junction structures causing Crohn's disease-like or psoriasis-like phenotypes.","method":"Live-cell imaging/fractionation (translocation), co-immunoprecipitation (myosin 6, β-catenin, ZO-1), conditional knockout mice (intestine-specific, inducible whole-body), patient tissue analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization with functional consequence, Co-IP of junctional partners, in vivo conditional KO with clear phenotype, patient tissue validation, single lab with multiple orthogonal methods","pmids":["34301883"],"is_preprint":false},{"year":2019,"finding":"In osteocytes, TSC1 promotes sclerostin secretion through inhibition of mTORC1 and downregulation of Sirt1 (a repressor of the sclerostin gene Sost); Tsc1 osteocyte-specific knockout constitutively activates mTORC1 and reduces sclerostin production, causing osteosclerosis; rapamycin restores sclerostin expression.","method":"Conditional knockout (DMP1-Cre), rapamycin treatment, TSC1 knockdown in osteocyte cell line, mTORC1 activity assay, sclerostin/Sost expression assay, mechanical loading","journal":"Open biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with pharmacological rescue and cell-based knockdown, single lab","pmids":["31088250"],"is_preprint":false},{"year":2018,"finding":"TSC1 is required for podosome belt formation in osteoclasts; TSC1 deletion reduces podosome superstructure assembly by releasing mTORC1-dependent negative feedback inhibition of Rac1/Cdc42, leading to bone resorption deficiency and osteopetrosis; rapamycin and active Rac1/Cdc42 restore podosome organization.","method":"Conditional knockout (osteoclast-specific), podosome/sealing zone imaging, Rac1/Cdc42 activity assays, rapamycin rescue, in vivo bone phenotype","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional KO with pharmacological/genetic rescue and GTPase activity assays, single lab","pmids":["29358671"],"is_preprint":false},{"year":2013,"finding":"Hamartin (TSC1) is selectively induced by ischemia in resistant hippocampal CA3 neurons and by ischemic preconditioning in CA1 neurons; TSC1 shRNA knockdown increases neuronal vulnerability to ischemia in vitro and in vivo; hamartin overexpression increases resistance to OGD by inducing productive autophagy through an mTORC1-dependent mechanism.","method":"shRNA knockdown in vitro and in vivo (viral vectors), OGD model, overexpression, autophagy assay, mTORC1 activity assay","journal":"Nature medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with mechanistic autophagy/mTORC1 readouts, single lab","pmids":["23435171"],"is_preprint":false},{"year":2002,"finding":"Hamartin and tuberin are multicompartmental proteins present in cytosolic, microsomal, and cytoskeletal compartments as a stable complex; in the microsomal fraction they behave as peripheral membrane proteins on the cytosolic leaflet; immunoisolation shows enrichment of Rap1, Rab5, and caveolin-1 in tuberin-bound vesicle fractions.","method":"Subcellular fractionation, co-immunoprecipitation, magnetic bead immunoisolation, carbonate extraction","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple fractionation approaches with co-IP, single lab, no direct functional consequence demonstrated","pmids":["12147258"],"is_preprint":false},{"year":2003,"finding":"Pam (a RING-zinc finger protein) associates with the tuberin-hamartin complex in the brain; the C-terminus of Pam (RING domain) binds tuberin; Pam co-localizes with tuberin and hamartin in neurites and growth cones. The Drosophila ortholog HIW genetically interacts with the Tsc1-Tsc2 complex and could negatively regulate its activity.","method":"Co-immunoprecipitation, co-localization (immunofluorescence), Drosophila genetic interaction","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP, genetic interaction in Drosophila, no direct functional assay on hamartin specifically","pmids":["14559897"],"is_preprint":false},{"year":2016,"finding":"VPS34 forms a protein complex with PIKFYVE and TSC1 at the plasma membrane via PI3P; this disengages TSC2 from the TSC1/TSC2 heterodimer, leading to TSC2 ubiquitination and degradation, thereby activating RheB and mTORC1/S6K1.","method":"Co-immunoprecipitation, ubiquitination assay, lipid kinase assay, VPS34 kinase-dead mutant","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with complex components, ubiquitination assay, kinase-dead mutant validation, single lab","pmids":["27409169"],"is_preprint":false}],"current_model":"TSC1 (hamartin) forms a heterodimeric complex with TSC2 (tuberin) via coiled-coil interactions; within this complex, TSC2 provides GAP activity toward the small GTPase Rheb, converting it to the inactive GDP-bound form and thereby suppressing mTORC1-mediated cell growth and protein synthesis. TSC1 stabilizes TSC2 by blocking HERC1-mediated ubiquitination, protects the complex from degradation, and recruits it to the lysosomal membrane via its N-terminal HEAT-repeat domain binding to PI3,5P2, enabling starvation-induced mTORC1 inactivation. Beyond this canonical mTORC1-regulatory role, TSC1 acts independently of TSC2 to regulate TGF-β-Smad2/3 signaling, tight junction formation (via myosin-6 and perijunctional actin anchoring), macrophage polarization through a Ras-Raf1-MEK-ERK pathway, and cell adhesion through ERM proteins and Rho/Rac1 GTPase regulation; it is also phosphorylated by CDK1 at G2/M and by IKKβ on Ser487/Ser511, which modulate complex function and link inflammatory signals to mTOR activation."},"narrative":{"mechanistic_narrative":"TSC1 (hamartin) is a tumor-suppressor protein that, in complex with TSC2 (tuberin), functions as the central negative regulator of mTORC1-driven cell growth and protein synthesis [PMID:9242607, PMID:12906785]. TSC1 and TSC2 associate directly through coiled-coil interactions, and patient-derived mutations in the binding interface abolish this association, linking complex integrity to disease [PMID:9580671, PMID:11741833]. Within the heterodimer, TSC2 supplies GTPase-activating activity toward the small GTPase Rheb, converting it to its inactive GDP-bound form to suppress mTORC1 and downstream S6K/4E-BP1 signaling [PMID:12906785]. TSC1 contributes essential regulatory functions: its N-terminal HEAT-repeat domain binds lysosomal phosphoinositides, particularly PI(3,5)P2, to recruit the complex to the lysosome for starvation-induced mTORC1 inactivation, a central helical domain mediates oligomerization, and the C-terminal coiled-coil engages TSC2 [PMID:33974911]. TSC1 stabilizes TSC2 by binding it and excluding the HERC1 E3 ubiquitin ligase, preventing TSC2 ubiquitination and degradation [PMID:11175345, PMID:16464865]. This stabilization is reversed by signals that dismantle the complex: IKKβ phosphorylates TSC1 at Ser487/Ser511 to suppress its function and activate mTOR-driven angiogenesis and tumor growth [PMID:17693255], and a VPS34–PIKFYVE complex at the plasma membrane disengages TSC2 from TSC1 to drive its degradation and Rheb/mTORC1 activation [PMID:27409169]. Beyond mTORC1 control, TSC1 acts independently of TSC2 to regulate cytoskeletal and signaling programs: it binds ERM proteins to activate Rho and promote stress fibers and focal adhesions [PMID:10806479], anchors the perijunctional actin cytoskeleton to β-catenin and ZO-1 via myosin 6 to enable tight junction formation in epithelia [PMID:34301883], restrains M1 macrophage polarization through a Ras–Raf1–MEK–ERK pathway [PMID:25175012], and participates in TGF-β–Smad2/3 signaling by associating with the receptor complex and Smads to control growth arrest and EMT [PMID:25727005]. Through its mTORC1-regulatory and cytoskeletal roles, TSC1 governs diverse physiological outputs including autophagy-mediated neuronal protection from ischemia [PMID:23435171], osteocyte sclerostin secretion [PMID:31088250], and osteoclast podosome assembly [PMID:29358671].","teleology":[{"year":1997,"claim":"Establishing TSC1 as a tumor suppressor defined the disease relevance and set the stage for mechanistic dissection of its growth-suppressive function.","evidence":"Positional cloning with LOH analysis in TSC-associated renal carcinoma","pmids":["9242607"],"confidence":"High","gaps":["Molecular function of the encoded protein not yet defined","No binding partners or pathway identified"]},{"year":1998,"claim":"Demonstrating a direct hamartin-tuberin physical interaction via coiled-coil domains established that the two TSC gene products act as one complex rather than in parallel.","evidence":"Co-immunoprecipitation, yeast two-hybrid, and domain mapping","pmids":["9580671"],"confidence":"High","gaps":["Biochemical activity of the complex unknown","Downstream effectors not identified"]},{"year":1998,"claim":"Showing hamartin localizes to membrane/particulate fractions independently of tuberin indicated TSC1 has subcellular targeting functions distinct from complex formation.","evidence":"Subcellular fractionation and immunofluorescence in tuberin-null Eker rat cells","pmids":["9809973"],"confidence":"Medium","gaps":["Identity of the membrane compartment unresolved","Lipid- or protein-binding basis of localization unknown"]},{"year":2000,"claim":"Linking hamartin to ERM proteins and Rho activation revealed a TSC1 role in actin/adhesion regulation separable from canonical growth suppression.","evidence":"Co-IP, dominant-negative inhibition, Rho activity and actin/focal adhesion assays","pmids":["10806479"],"confidence":"High","gaps":["Relationship to mTOR pathway not addressed","In vivo relevance not tested"]},{"year":2000,"claim":"Demonstrating that hamartin stabilizes tuberin by preventing its ubiquitination explained how TSC1 loss destabilizes the whole complex.","evidence":"Co-transfection, ubiquitination assay, pulse-chase","pmids":["11175345"],"confidence":"High","gaps":["Identity of the responsible E3 ligase not yet known","Mechanism of protection (steric vs. competitive) unresolved"]},{"year":2001,"claim":"Fine-mapping the interaction interface and showing disease mutations disrupt binding connected complex integrity directly to TSC pathology.","evidence":"Yeast two-hybrid, Co-IP, and pathological mutation analysis","pmids":["11741833"],"confidence":"High","gaps":["Structural basis of the interface not resolved at this stage","Effect on downstream signaling not measured"]},{"year":2003,"claim":"Identifying the TSC1-TSC2 complex as a Rheb GAP placed TSC1 at the heart of nutrient/mTOR signaling and unified its growth-suppressive role.","evidence":"In vitro GAP assay, epistasis, S6K1 readout, rapamycin sensitivity, patient mutants","pmids":["12906785"],"confidence":"High","gaps":["TSC1's precise contribution to GAP activity vs. TSC2 not dissected","Spatial regulation of GAP function unknown"]},{"year":2003,"claim":"Connecting the complex to GSK3β/Axin and β-catenin degradation extended TSC1/TSC2 influence to Wnt signaling.","evidence":"Co-IP, luciferase reporter, β-catenin half-life measurement","pmids":["12511557"],"confidence":"Medium","gaps":["Direct vs. indirect role of TSC1 in the degradation complex unclear","In vivo significance not established"]},{"year":2003,"claim":"Identifying CDK1-mediated phosphorylation of hamartin at G2/M sites established cell-cycle kinase control of complex activity.","evidence":"In vitro kinase assay, cell-cycle synchronization, site-directed mutagenesis, S6K readout","pmids":["14551205"],"confidence":"High","gaps":["Physiological consequence of phosphorylation in vivo not defined","Whether phosphorylation alters localization not tested"]},{"year":2006,"claim":"Showing TSC1 excludes the HERC1 E3 ligase from TSC2 provided the molecular mechanism for TSC1-dependent stabilization of tuberin.","evidence":"Reciprocal Co-IP, ubiquitination assay, patient TSC2 mutant analysis","pmids":["16464865"],"confidence":"High","gaps":["Regulation of HERC1 access under physiological signals unknown","Structural mode of exclusion not resolved"]},{"year":2006,"claim":"Distinguishing opposite effects of TSC1/TSC2 on mTORC1 versus mTORC2 refined the complex's role in two distinct mTOR outputs.","evidence":"Knockdown/overexpression in Drosophila S2 and HEK293 cells, S6K and Akt readouts","pmids":["16627617"],"confidence":"Medium","gaps":["Mechanism of TORC2 activation by the complex unknown","TSC1-specific contribution not separated"]},{"year":2007,"claim":"Identifying IKKβ phosphorylation of TSC1 at Ser487/Ser511 linked inflammatory signaling to mTOR activation and tumor angiogenesis.","evidence":"Co-IP, in vitro kinase assay, site mutagenesis, tumor IHC and angiogenesis assays","pmids":["17693255"],"confidence":"High","gaps":["How phosphorylation mechanistically suppresses TSC1 (degradation vs. dissociation) not fully resolved","Reversal/phosphatase not identified"]},{"year":2014,"claim":"Demonstrating mTOR-independent control of M1 macrophage polarization through Ras-Raf1-MEK-ERK established a genuinely TSC2/mTOR-independent TSC1 function.","evidence":"Myeloid-specific Tsc1 knockout mice, rapamycin and mTOR deletion, ERK pathway analysis","pmids":["25175012"],"confidence":"High","gaps":["Direct molecular link between TSC1 and Ras-Raf1 unresolved","Whether TSC1 acts as scaffold or enzyme here unknown"]},{"year":2015,"claim":"Showing TSC1 acts independently of TSC2 within the TGF-β-Smad2/3 pathway broadened its signaling repertoire beyond mTOR.","evidence":"Co-IP with receptor complex and Smads, Smad phosphorylation, EMT and target gene assays","pmids":["25727005"],"confidence":"High","gaps":["Structural basis of TSC1-Smad/receptor binding unknown","How TSC1 partitions between TSC2-dependent and -independent pools unresolved"]},{"year":2021,"claim":"Defining TSC1's three-domain architecture and PI(3,5)P2-dependent lysosomal recruitment revealed how TSC1 spatially targets the complex for starvation-induced mTORC1 inactivation.","evidence":"Domain mapping, PIP lipid-binding assay, lysosomal recruitment and mTORC1 activity assays, conservation analysis","pmids":["33974911"],"confidence":"High","gaps":["Regulation of PI(3,5)P2 levels controlling recruitment not detailed","Dynamics of recruitment under fed vs. starved states not fully kinetically resolved"]},{"year":2021,"claim":"Demonstrating TSC1 translocation to cell junctions and myosin-6-dependent anchoring of perijunctional actin established a structural, mTORC1-independent role in epithelial barrier integrity.","evidence":"Live-cell imaging, Co-IP of myosin 6/β-catenin/ZO-1, intestine- and skin-specific knockout mice, patient tissue","pmids":["34301883"],"confidence":"High","gaps":["Signal triggering TSC1 junctional translocation unknown","Relationship between junctional and lysosomal TSC1 pools unresolved"]},{"year":null,"claim":"How TSC1 is partitioned among its distinct functional pools — lysosomal TSC2-bound GAP complex, junctional cytoskeletal anchor, and TSC2-independent signaling scaffold — and what governs switching between them remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of TSC1 pool allocation","Upstream determinants directing TSC1 to TSC2-independent functions unknown","Structural details of TSC1's TSC2-independent complexes lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,4,15]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[23]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[24,22]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[3,24]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[23]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[28,2]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[30,24]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[3,24,28]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[13]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[20]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,18,22,21]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[27]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,18]}],"complexes":["TSC1-TSC2 (hamartin-tuberin) complex","VPS34-PIKFYVE-TSC1 complex"],"partners":["TSC2","RHEB","HERC1","IKBKB","EZR","MYO6","SMAD2","PLK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92574","full_name":"Hamartin","aliases":["Tuberous sclerosis 1 protein"],"length_aa":1164,"mass_kda":129.8,"function":"Non-catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12906785, PubMed:15340059, PubMed:24529379, PubMed:28215400). The TSC-TBC complex acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12906785, PubMed:15340059, PubMed:24529379). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12271141, PubMed:24529379, PubMed:28215400, PubMed:33215753). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Within the TSC-TBC complex, TSC1 stabilizes TSC2 and prevents TSC2 self-aggregation (PubMed:10585443, PubMed:28215400). Acts as a tumor suppressor (PubMed:9242607). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also acts as a co-chaperone for HSP90AA1 facilitating HSP90AA1 chaperoning of protein clients such as kinases, TSC2 and glucocorticoid receptor NR3C1 (PubMed:29127155). Increases ATP binding to HSP90AA1 and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:29127155). Recruits TSC2 to HSP90AA1 and stabilizes TSC2 by preventing the interaction between TSC2 and ubiquitin ligase HERC1 (PubMed:16464865, PubMed:29127155)","subcellular_location":"Lysosome membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q92574/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TSC1","classification":"Not Classified","n_dependent_lines":129,"n_total_lines":1208,"dependency_fraction":0.10678807947019868},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TSC1","total_profiled":1310},"omim":[{"mim_id":"618956","title":"RHEB-LIKE PROTEIN 1; RHEBL1","url":"https://www.omim.org/entry/618956"},{"mim_id":"615730","title":"DEDICATOR OF CYTOKINESIS 7; DOCK7","url":"https://www.omim.org/entry/615730"},{"mim_id":"613254","title":"TUBEROUS SCLEROSIS 2; TSC2","url":"https://www.omim.org/entry/613254"},{"mim_id":"612655","title":"TBC1 DOMAIN FAMILY, MEMBER 7; TBC1D7","url":"https://www.omim.org/entry/612655"},{"mim_id":"610392","title":"MYC-BINDING PROTEIN 2; MYCBP2","url":"https://www.omim.org/entry/610392"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Lipid droplets","reliability":"Additional"},{"location":"Primary cilium transition zone","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TSC1"},"hgnc":{"alias_symbol":["KIAA0243","LAM","hamartin"],"prev_symbol":["TSC"]},"alphafold":{"accession":"Q92574","domains":[{"cath_id":"1.25.40","chopping":"1-106","consensus_level":"medium","plddt":83.593,"start":1,"end":106}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92574","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92574-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92574-F1-predicted_aligned_error_v6.png","plddt_mean":62.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TSC1","jax_strain_url":"https://www.jax.org/strain/search?query=TSC1"},"sequence":{"accession":"Q92574","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92574.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92574/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92574"}},"corpus_meta":[{"pmid":"9242607","id":"PMC_9242607","title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9242607","citation_count":1287,"is_preprint":false},{"pmid":"18466115","id":"PMC_18466115","title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18466115","citation_count":1001,"is_preprint":false},{"pmid":"12906785","id":"PMC_12906785","title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12906785","citation_count":986,"is_preprint":false},{"pmid":"11112665","id":"PMC_11112665","title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11112665","citation_count":735,"is_preprint":false},{"pmid":"22763451","id":"PMC_22763451","title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22763451","citation_count":692,"is_preprint":false},{"pmid":"17693255","id":"PMC_17693255","title":"IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17693255","citation_count":545,"is_preprint":false},{"pmid":"9580671","id":"PMC_9580671","title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9580671","citation_count":438,"is_preprint":false},{"pmid":"16286931","id":"PMC_16286931","title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.","date":"2005","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16286931","citation_count":393,"is_preprint":false},{"pmid":"10205261","id":"PMC_10205261","title":"Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10205261","citation_count":382,"is_preprint":false},{"pmid":"11390358","id":"PMC_11390358","title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11390358","citation_count":380,"is_preprint":false},{"pmid":"14614311","id":"PMC_14614311","title":"Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.","date":"2003","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14614311","citation_count":271,"is_preprint":false},{"pmid":"10806479","id":"PMC_10806479","title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10806479","citation_count":269,"is_preprint":false},{"pmid":"25175012","id":"PMC_25175012","title":"TSC1 controls macrophage polarization to prevent inflammatory disease.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25175012","citation_count":256,"is_preprint":false},{"pmid":"9809973","id":"PMC_9809973","title":"Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9809973","citation_count":217,"is_preprint":false},{"pmid":"11175345","id":"PMC_11175345","title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11175345","citation_count":204,"is_preprint":false},{"pmid":"23435171","id":"PMC_23435171","title":"Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy.","date":"2013","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23435171","citation_count":192,"is_preprint":false},{"pmid":"16464865","id":"PMC_16464865","title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16464865","citation_count":186,"is_preprint":false},{"pmid":"31961824","id":"PMC_31961824","title":"Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31961824","citation_count":171,"is_preprint":false},{"pmid":"28215400","id":"PMC_28215400","title":"Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28215400","citation_count":158,"is_preprint":false},{"pmid":"16627617","id":"PMC_16627617","title":"TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16627617","citation_count":149,"is_preprint":false},{"pmid":"21907282","id":"PMC_21907282","title":"Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.","date":"2011","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/21907282","citation_count":140,"is_preprint":false},{"pmid":"21403402","id":"PMC_21403402","title":"Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21403402","citation_count":140,"is_preprint":false},{"pmid":"11829138","id":"PMC_11829138","title":"Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.","date":"2002","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11829138","citation_count":115,"is_preprint":false},{"pmid":"24270422","id":"PMC_24270422","title":"TSC1 regulates the balance between effector and regulatory T cells.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24270422","citation_count":114,"is_preprint":false},{"pmid":"28222202","id":"PMC_28222202","title":"TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review.","date":"2017","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28222202","citation_count":111,"is_preprint":false},{"pmid":"12781866","id":"PMC_12781866","title":"Tumour suppressors hamartin and tuberin: intracellular signalling.","date":"2003","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/12781866","citation_count":105,"is_preprint":false},{"pmid":"10915759","id":"PMC_10915759","title":"The TSC1 gene product, hamartin, negatively regulates cell proliferation.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10915759","citation_count":104,"is_preprint":false},{"pmid":"18291711","id":"PMC_18291711","title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.","date":"2008","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/18291711","citation_count":103,"is_preprint":false},{"pmid":"16959613","id":"PMC_16959613","title":"Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16959613","citation_count":103,"is_preprint":false},{"pmid":"22021912","id":"PMC_22021912","title":"GABAergic interneuron development and function is modulated by the Tsc1 gene.","date":"2011","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22021912","citation_count":103,"is_preprint":false},{"pmid":"11208653","id":"PMC_11208653","title":"The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.","date":"2001","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11208653","citation_count":103,"is_preprint":false},{"pmid":"10353610","id":"PMC_10353610","title":"Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10353610","citation_count":97,"is_preprint":false},{"pmid":"35072947","id":"PMC_35072947","title":"GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.","date":"2022","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35072947","citation_count":95,"is_preprint":false},{"pmid":"15611338","id":"PMC_15611338","title":"TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15611338","citation_count":93,"is_preprint":false},{"pmid":"11741833","id":"PMC_11741833","title":"Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11741833","citation_count":92,"is_preprint":false},{"pmid":"21329690","id":"PMC_21329690","title":"TSC1/TSC2 signaling in the CNS.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21329690","citation_count":87,"is_preprint":false},{"pmid":"24599401","id":"PMC_24599401","title":"Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24599401","citation_count":87,"is_preprint":false},{"pmid":"14718525","id":"PMC_14718525","title":"Tsc1+ and tsc2+ regulate arginine uptake and metabolism in Schizosaccharomyces pombe.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14718525","citation_count":86,"is_preprint":false},{"pmid":"12511557","id":"PMC_12511557","title":"The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12511557","citation_count":86,"is_preprint":false},{"pmid":"15951164","id":"PMC_15951164","title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.","date":"2005","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/15951164","citation_count":84,"is_preprint":false},{"pmid":"11290735","id":"PMC_11290735","title":"Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11290735","citation_count":82,"is_preprint":false},{"pmid":"18032745","id":"PMC_18032745","title":"Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18032745","citation_count":82,"is_preprint":false},{"pmid":"21309039","id":"PMC_21309039","title":"Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21309039","citation_count":80,"is_preprint":false},{"pmid":"22791749","id":"PMC_22791749","title":"Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22791749","citation_count":71,"is_preprint":false},{"pmid":"21805467","id":"PMC_21805467","title":"Regulation of T-cell survival and mitochondrial homeostasis by TSC1.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21805467","citation_count":71,"is_preprint":false},{"pmid":"14559897","id":"PMC_14559897","title":"Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14559897","citation_count":70,"is_preprint":false},{"pmid":"19008302","id":"PMC_19008302","title":"Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19008302","citation_count":70,"is_preprint":false},{"pmid":"16339216","id":"PMC_16339216","title":"Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16339216","citation_count":67,"is_preprint":false},{"pmid":"16357142","id":"PMC_16357142","title":"Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16357142","citation_count":66,"is_preprint":false},{"pmid":"14551205","id":"PMC_14551205","title":"Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14551205","citation_count":65,"is_preprint":false},{"pmid":"16206276","id":"PMC_16206276","title":"Hamartin and tuberin: working together for tumour suppression.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16206276","citation_count":63,"is_preprint":false},{"pmid":"10349994","id":"PMC_10349994","title":"The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.","date":"1999","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/10349994","citation_count":60,"is_preprint":false},{"pmid":"19419980","id":"PMC_19419980","title":"TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19419980","citation_count":60,"is_preprint":false},{"pmid":"9989450","id":"PMC_9989450","title":"Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.","date":"1999","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/9989450","citation_count":60,"is_preprint":false},{"pmid":"11437991","id":"PMC_11437991","title":"Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.","date":"2001","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/11437991","citation_count":59,"is_preprint":false},{"pmid":"22891340","id":"PMC_22891340","title":"Tumor suppressor TSC1 is critical for T-cell anergy.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22891340","citation_count":56,"is_preprint":false},{"pmid":"25727005","id":"PMC_25727005","title":"TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.","date":"2015","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25727005","citation_count":55,"is_preprint":false},{"pmid":"27601261","id":"PMC_27601261","title":"NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27601261","citation_count":53,"is_preprint":false},{"pmid":"31780742","id":"PMC_31780742","title":"Tsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31780742","citation_count":51,"is_preprint":false},{"pmid":"11444800","id":"PMC_11444800","title":"Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.","date":"2001","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11444800","citation_count":47,"is_preprint":false},{"pmid":"11266527","id":"PMC_11266527","title":"Hamartin and tuberin expression in human tissues.","date":"2001","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/11266527","citation_count":45,"is_preprint":false},{"pmid":"33974911","id":"PMC_33974911","title":"TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33974911","citation_count":45,"is_preprint":false},{"pmid":"31676823","id":"PMC_31676823","title":"Tsc1 represses parvalbumin expression and fast-spiking properties in somatostatin lineage cortical interneurons.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31676823","citation_count":44,"is_preprint":false},{"pmid":"10663963","id":"PMC_10663963","title":"Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.","date":"2000","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/10663963","citation_count":41,"is_preprint":false},{"pmid":"29396625","id":"PMC_29396625","title":"TSC1 and TSC2 regulate cilia length and canonical Hedgehog signaling via different mechanisms.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/29396625","citation_count":39,"is_preprint":false},{"pmid":"29358671","id":"PMC_29358671","title":"TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42.","date":"2018","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29358671","citation_count":37,"is_preprint":false},{"pmid":"15562827","id":"PMC_15562827","title":"The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.","date":"2004","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/15562827","citation_count":37,"is_preprint":false},{"pmid":"35119931","id":"PMC_35119931","title":"Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35119931","citation_count":36,"is_preprint":false},{"pmid":"17308101","id":"PMC_17308101","title":"TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17308101","citation_count":35,"is_preprint":false},{"pmid":"15661536","id":"PMC_15661536","title":"TSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?","date":"2005","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/15661536","citation_count":35,"is_preprint":false},{"pmid":"30733194","id":"PMC_30733194","title":"Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30733194","citation_count":34,"is_preprint":false},{"pmid":"12147258","id":"PMC_12147258","title":"Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.","date":"2002","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/12147258","citation_count":33,"is_preprint":false},{"pmid":"27593484","id":"PMC_27593484","title":"TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.","date":"2015","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27593484","citation_count":33,"is_preprint":false},{"pmid":"10805093","id":"PMC_10805093","title":"Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.","date":"2000","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/10805093","citation_count":32,"is_preprint":false},{"pmid":"31433805","id":"PMC_31433805","title":"TSC1/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31433805","citation_count":32,"is_preprint":false},{"pmid":"16412252","id":"PMC_16412252","title":"Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers.","date":"2006","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16412252","citation_count":32,"is_preprint":false},{"pmid":"10807585","id":"PMC_10807585","title":"Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney.","date":"2000","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10807585","citation_count":31,"is_preprint":false},{"pmid":"33575875","id":"PMC_33575875","title":"Role of TSC1 in physiology and diseases.","date":"2021","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33575875","citation_count":30,"is_preprint":false},{"pmid":"26159807","id":"PMC_26159807","title":"Tsc1 is a Critical Regulator of Macrophage Survival and Function.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26159807","citation_count":30,"is_preprint":false},{"pmid":"15963462","id":"PMC_15963462","title":"Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15963462","citation_count":30,"is_preprint":false},{"pmid":"38411613","id":"PMC_38411613","title":"The mTOR pathway genes MTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38411613","citation_count":29,"is_preprint":false},{"pmid":"32410883","id":"PMC_32410883","title":"Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32410883","citation_count":29,"is_preprint":false},{"pmid":"29196670","id":"PMC_29196670","title":"Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29196670","citation_count":27,"is_preprint":false},{"pmid":"11564212","id":"PMC_11564212","title":"Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.","date":"2001","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/11564212","citation_count":27,"is_preprint":false},{"pmid":"30087333","id":"PMC_30087333","title":"TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway.","date":"2018","source":"Emerging microbes & infections","url":"https://pubmed.ncbi.nlm.nih.gov/30087333","citation_count":26,"is_preprint":false},{"pmid":"20658316","id":"PMC_20658316","title":"Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes.","date":"2010","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/20658316","citation_count":26,"is_preprint":false},{"pmid":"11307618","id":"PMC_11307618","title":"Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.","date":"2001","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/11307618","citation_count":25,"is_preprint":false},{"pmid":"25565629","id":"PMC_25565629","title":"Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25565629","citation_count":25,"is_preprint":false},{"pmid":"27409169","id":"PMC_27409169","title":"VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27409169","citation_count":25,"is_preprint":false},{"pmid":"22674026","id":"PMC_22674026","title":"Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules.","date":"2012","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22674026","citation_count":25,"is_preprint":false},{"pmid":"27640314","id":"PMC_27640314","title":"Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.","date":"2016","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/27640314","citation_count":24,"is_preprint":false},{"pmid":"15072102","id":"PMC_15072102","title":"Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.","date":"2004","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15072102","citation_count":23,"is_preprint":false},{"pmid":"33767704","id":"PMC_33767704","title":"TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33767704","citation_count":23,"is_preprint":false},{"pmid":"23749404","id":"PMC_23749404","title":"Comparative analysis of Tsc1 and Tsc2 single and double radial glial cell mutants.","date":"2013","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23749404","citation_count":23,"is_preprint":false},{"pmid":"18368626","id":"PMC_18368626","title":"Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.","date":"2008","source":"Folia neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/18368626","citation_count":23,"is_preprint":false},{"pmid":"31335987","id":"PMC_31335987","title":"PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31335987","citation_count":23,"is_preprint":false},{"pmid":"11329144","id":"PMC_11329144","title":"The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.","date":"2001","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11329144","citation_count":22,"is_preprint":false},{"pmid":"16552619","id":"PMC_16552619","title":"Hamartin and tuberin modulate gene transcription via beta-catenin.","date":"2006","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16552619","citation_count":21,"is_preprint":false},{"pmid":"34301883","id":"PMC_34301883","title":"Tsc1 regulates tight junction independent of mTORC1.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34301883","citation_count":21,"is_preprint":false},{"pmid":"31088250","id":"PMC_31088250","title":"Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.","date":"2019","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/31088250","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49012,"output_tokens":7428,"usd":0.129228,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16745,"output_tokens":5035,"usd":0.1048,"stage2_stop_reason":"end_turn"},"total_usd":0.234028,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"TSC1 encodes a 130 kDa protein (hamartin) that acts as a tumor suppressor; somatic mutation of the wild-type allele was found in a TSC-associated renal carcinoma, consistent with a two-hit tumor suppressor model.\",\n      \"method\": \"Positional cloning, mutation analysis, loss-of-heterozygosity analysis in tumor tissue\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — original gene identification with direct molecular evidence (somatic LOH in tumor), widely replicated\",\n      \"pmids\": [\"9242607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hamartin (TSC1) and tuberin (TSC2) physically associate in vivo, and this interaction is mediated by predicted coiled-coil domains in both proteins, indicating they function together in the same complex.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, domain mapping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP at endogenous levels, replicated by multiple independent labs\",\n      \"pmids\": [\"9580671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hamartin localizes to the membrane/particulate (P100) fraction of cells and displays a punctate cytoplasmic immunofluorescence pattern consistent with cytoplasmic vesicles; this localization is independent of tuberin.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence microscopy\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — fractionation and IF from a single lab, replicated in Eker rat cells lacking tuberin\",\n      \"pmids\": [\"9809973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hamartin interacts with the ezrin-radixin-moesin (ERM) family of actin-binding proteins; overexpression of hamartin activates the small GTPase Rho, induces actin stress fiber assembly and focal adhesion formation, whereas inhibition of hamartin causes loss of adhesion. Endogenous hamartin-ERM interaction is required for Rho activation by serum or LPA.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative inhibition, overexpression, Rho activity assays, actin/focal adhesion staining\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, functional assays, dominant-negative), single lab with rigorous controls\",\n      \"pmids\": [\"10806479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hamartin stabilizes tuberin by binding to it and preventing its ubiquitination; the fraction of tuberin bound to hamartin is not ubiquitinated, whereas unbound tuberin is highly ubiquitinated and degraded. Co-expression of tuberin also stabilizes hamartin.\",\n      \"method\": \"Co-transfection, immunoprecipitation, ubiquitination assay, pulse-chase\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct biochemical demonstration of ubiquitination protection, multiple constructs and mutants tested\",\n      \"pmids\": [\"11175345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Ectopic hamartin expression inhibits cell proliferation and arrests cells in G1 phase; this growth-inhibitory effect depends on the coiled-coil domain implicated in tuberin binding.\",\n      \"method\": \"Overexpression, cell proliferation assay, cell cycle analysis, domain-deletion constructs\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional overexpression with domain mapping, single lab\",\n      \"pmids\": [\"10915759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hamartin (amino acids 302–430) and tuberin (amino acids 1–418, requiring a coiled-coil region at 346–371 plus additional N-terminal residues) directly interact; TSC patient-derived pathological mutations within these binding regions abolish or dramatically reduce hamartin-tuberin interaction in yeast two-hybrid and co-IP assays.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, pathological mutation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two orthogonal binding assays, pathological vs. non-pathogenic mutant discrimination, single lab\",\n      \"pmids\": [\"11741833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tuberin phosphorylation at serine and tyrosine residues regulates its interaction with hamartin; disease-associated TSC2 mutations (Y1571H, P1675L) reduce tuberin phosphorylation, decrease TSC1-TSC2 interaction, and impair tuberin's growth-inhibitory function.\",\n      \"method\": \"Phosphorylation assays, co-immunoprecipitation, growth inhibition assays, patient-derived mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct phosphorylation-interaction linkage with disease mutants, single lab\",\n      \"pmids\": [\"11290735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hamartin and tuberin interact with and co-localize with CDK1 (cdc2) and its regulatory partners cyclin B1 and cyclin A in multiple cell types, suggesting a direct role for both proteins in modulating CDK1 activity at the G2/M transition.\",\n      \"method\": \"Co-immunoprecipitation, confocal co-localization\",\n      \"journal\": \"Journal of neuropathology and experimental neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP/co-localization, single lab, no functional mechanistic follow-up\",\n      \"pmids\": [\"11444800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The TSC1-TSC2 (hamartin-tuberin) heterodimer acts as a GTPase-activating protein (GAP) for the small GTPase Rheb in vitro; Rheb mediates nutrient/mTOR signaling upstream of mTOR and downstream of TSC1/TSC2. Patient-derived tuberin GAP domain mutants could not inactivate Rheb, placing TSC1/TSC2 as a GAP complex for Rheb to negatively regulate mTORC1.\",\n      \"method\": \"In vitro GAP assay, overexpression epistasis, S6K1 phosphorylation readout, rapamycin sensitivity, patient-derived mutants\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstituted GAP assay plus multiple cellular epistasis experiments; independently replicated\",\n      \"pmids\": [\"12906785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The tuberin-hamartin complex co-immunoprecipitates with glycogen synthase kinase 3β (GSK3β) and Axin in a Wnt-1-dependent manner and negatively regulates β-catenin stability and TCF/LEF transcriptional activity by participating in the β-catenin degradation complex.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, β-catenin stability/half-life measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with multiple complex components, reporter assay, single lab\",\n      \"pmids\": [\"12511557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cyclin-dependent kinase 1 (CDK1)/cyclin B phosphorylates hamartin at Thr417 (within the hamartin-tuberin interaction domain) and two other sites during G2/M; phospho-hamartin still interacts with tuberin; alanine mutations at all three CDK1 sites increase the inhibitory activity of the hamartin-tuberin complex on p70S6K.\",\n      \"method\": \"In vitro kinase assay, cell-cycle synchronization, site-directed mutagenesis, S6K phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with mutagenesis and functional readout in cells, single lab\",\n      \"pmids\": [\"14551205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TSC2 modulates actin dynamics and focal adhesion through the TSC1-binding domain (HBD); TSC2 expression promotes Rac1 activation and inhibits Rho, leading to stress fiber disassembly. TSC1 siRNA knockdown in TSC2-null cells activates Rac1, demonstrating that TSC1 inhibits Rac1 and TSC2 blocks this TSC1 activity.\",\n      \"method\": \"siRNA knockdown, Rac1/Rho activity assays, domain constructs, actin/focal adhesion staining\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and biochemical dissection in TSC2-null cells with domain constructs, single lab\",\n      \"pmids\": [\"15611338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hamartin localizes to the centrosome and interacts with polo-like kinase 1 (Plk1) in a phosphorylation-dependent manner; the interaction requires phosphorylation of Thr310 on hamartin. Hamartin negatively regulates Plk1 protein levels. Tsc1-null MEFs exhibit increased centrosome number and DNA content, rescued by rapamycin but not Plk1 RNAi.\",\n      \"method\": \"Immunofluorescence (centrosome localization), co-immunoprecipitation, site-directed mutagenesis (T310A), immunoblot, rapamycin rescue, RNAi\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with phospho-mutant, centrosome localization by IF, functional Tsc1-null MEF phenotype, single lab\",\n      \"pmids\": [\"16339216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cyclin D1 (and other D-type cyclins) negatively regulate TSC1-TSC2: coexpression of cyclin D1-CDK4/6 increases phosphorylation and decreases steady-state levels of both TSC2 and TSC1, and promotes phosphorylation of mTOR substrates 4E-BP1 and S6K1. Cyclin D1 also down-regulates TSC proteins independently of CDK4/6.\",\n      \"method\": \"Co-expression, immunoblot, mTOR substrate phosphorylation assay, CDK4/6-independent mutant cyclin D1\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple constructs and conditions tested, single lab, no direct kinase assay on TSC1\",\n      \"pmids\": [\"16357142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC1 stabilizes TSC2 by excluding the HERC1 E3 ubiquitin ligase from the TSC2 complex; disease mutations in TSC2 that cause its destabilization allow HERC1 binding even in the presence of TSC1.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, patient-derived TSC2 mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ubiquitination assay, mechanistic explanation via mutant analysis, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"16464865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC1/TSC2 loss impairs NF-κB activation and cell survival after DNA damage or TNFα; rapamycin-mediated inhibition of deregulated mTOR activity in TSC2-null cells restores NF-κB activation and survival, identifying a crosstalk between the TSC/Rheb/mTOR and NF-κB pathways.\",\n      \"method\": \"TSC1/TSC2-deficient MEFs, NF-κB reporter assay, survival assay, rapamycin treatment, reconstitution\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in null MEFs with pharmacological rescue, single lab\",\n      \"pmids\": [\"16959613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSC1/TSC2 have differential effects on mTORC1 and mTORC2: TSC1/TSC2 negatively regulates TORC1 and positively regulates TORC2 activity; Rheb activates TORC1 but inhibits TORC2 (via a feedback through TORC1/S6K).\",\n      \"method\": \"Genetic knockdown/overexpression in Drosophila S2 cells and HEK293 cells, S6K and Akt phosphorylation as TORC1/2 readouts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays in two cell systems, single lab\",\n      \"pmids\": [\"16627617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IKKβ physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1 function and consequent mTOR pathway activation, enhanced angiogenesis, and tumor development.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, IHC in tumor samples, functional angiogenesis/tumor assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay identifying specific phosphorylation sites on TSC1, Co-IP, functional tumor phenotype, validated in human tumors\",\n      \"pmids\": [\"17693255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TSC1 loss causes increased translation of nucleophosmin mRNA via mTOR activation, leading to greater nucleophosmin protein, enhanced nuclear export of ribosome subunits, higher overall rates of protein synthesis, and increased proliferation; TSC1 re-introduction suppresses nucleophosmin accumulation.\",\n      \"method\": \"Tsc1 genetic ablation, polysome profiling, ribosome export assay, TSC1 reconstitution, rapamycin treatment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation plus reconstitution with multiple readouts, single lab\",\n      \"pmids\": [\"17308101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zebrafish tsc1a morpholino knockdown causes ciliary phenotypes (kidney cysts, left-right asymmetry defects) and elongated cilia; tsc1a acts synthetically with ciliary genes; Tsc1a localizes to the Golgi; mTOR pathway is aberrantly activated in ciliary mutants resembling tsc1a knockdown; rapamycin blocks cyst formation in ciliary mutants.\",\n      \"method\": \"Morpholino knockdown, genetic interaction (synthetic lethality), immunofluorescence localization, rapamycin rescue\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — morpholino knockdown with genetic interaction and pharmacological rescue, zebrafish model, single lab\",\n      \"pmids\": [\"19008302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TSC1 inhibits M1 macrophage polarization via a Ras GTPase-Raf1-MEK-ERK pathway independently of mTOR, and promotes M2 polarization via an mTOR-dependent C/EBPβ pathway; deletion of mTOR fails to reverse the enhanced M1 response of TSC1-deficient macrophages.\",\n      \"method\": \"Myeloid-specific TSC1 knockout mice, rapamycin treatment, mTOR deletion, ERK pathway analysis, cytokine assays, asthma model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional KO, pharmacological and genetic mTOR inhibition, identification of mTOR-independent ERK pathway, multiple orthogonal methods\",\n      \"pmids\": [\"25175012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TSC1 functions independently of TSC2 as a component of the TGF-β-Smad2/3 pathway: TSC1 interacts with the TGF-β receptor complex and Smad2/3, is required for their association, and regulates TGF-β-induced Smad2/3 phosphorylation, target gene expression, growth arrest, and EMT. Hyperactive Akt activates TSC1-dependent cytostatic Smad signaling.\",\n      \"method\": \"Co-immunoprecipitation, Smad phosphorylation assay, gene expression (target genes), loss-of-function (TSC1 KD), EMT assay, Akt activation\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP with receptor complex and Smads, functional KD with multiple readouts (phosphorylation, transcription, EMT), TSC2-independent mechanism established, single lab with orthogonal methods\",\n      \"pmids\": [\"25727005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TSC1 contains three structural domains: a C-terminal coiled-coil interacting with TSC2, a central helical domain mediating TSC1 oligomerization, and an N-terminal HEAT repeat domain that binds lysosomal phosphatidylinositol phosphates (PIPs), particularly PI3,5P2. Lysosomal recruitment of the TSC complex and subsequent mTORC1 inactivation upon starvation require TSC1 binding to PI3,5P2. TSC1 architecture and membrane binding are conserved from fungi to humans.\",\n      \"method\": \"Structural characterization (domain mapping), lipid-binding assay (PIP binding), lysosomal recruitment assay, mTORC1 activity assay under starvation, conservation analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural domain definition with functional lipid-binding and lysosomal recruitment assays plus mTORC1 functional readout, mechanistically rigorous\",\n      \"pmids\": [\"33974911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TSC1, but not TSC2, migrates from the cytoplasm to junctional membranes when epithelial cells establish contact; at junctions, TSC1 binds myosin 6 to anchor the perijunctional actin cytoskeleton to β-catenin and ZO-1, enabling tight junction formation independent of mTORC1. Intestine- or skin-specific Tsc1 ablation disrupts tight/adherens junction structures causing Crohn's disease-like or psoriasis-like phenotypes.\",\n      \"method\": \"Live-cell imaging/fractionation (translocation), co-immunoprecipitation (myosin 6, β-catenin, ZO-1), conditional knockout mice (intestine-specific, inducible whole-body), patient tissue analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization with functional consequence, Co-IP of junctional partners, in vivo conditional KO with clear phenotype, patient tissue validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34301883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In osteocytes, TSC1 promotes sclerostin secretion through inhibition of mTORC1 and downregulation of Sirt1 (a repressor of the sclerostin gene Sost); Tsc1 osteocyte-specific knockout constitutively activates mTORC1 and reduces sclerostin production, causing osteosclerosis; rapamycin restores sclerostin expression.\",\n      \"method\": \"Conditional knockout (DMP1-Cre), rapamycin treatment, TSC1 knockdown in osteocyte cell line, mTORC1 activity assay, sclerostin/Sost expression assay, mechanical loading\",\n      \"journal\": \"Open biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with pharmacological rescue and cell-based knockdown, single lab\",\n      \"pmids\": [\"31088250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TSC1 is required for podosome belt formation in osteoclasts; TSC1 deletion reduces podosome superstructure assembly by releasing mTORC1-dependent negative feedback inhibition of Rac1/Cdc42, leading to bone resorption deficiency and osteopetrosis; rapamycin and active Rac1/Cdc42 restore podosome organization.\",\n      \"method\": \"Conditional knockout (osteoclast-specific), podosome/sealing zone imaging, Rac1/Cdc42 activity assays, rapamycin rescue, in vivo bone phenotype\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional KO with pharmacological/genetic rescue and GTPase activity assays, single lab\",\n      \"pmids\": [\"29358671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hamartin (TSC1) is selectively induced by ischemia in resistant hippocampal CA3 neurons and by ischemic preconditioning in CA1 neurons; TSC1 shRNA knockdown increases neuronal vulnerability to ischemia in vitro and in vivo; hamartin overexpression increases resistance to OGD by inducing productive autophagy through an mTORC1-dependent mechanism.\",\n      \"method\": \"shRNA knockdown in vitro and in vivo (viral vectors), OGD model, overexpression, autophagy assay, mTORC1 activity assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with mechanistic autophagy/mTORC1 readouts, single lab\",\n      \"pmids\": [\"23435171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hamartin and tuberin are multicompartmental proteins present in cytosolic, microsomal, and cytoskeletal compartments as a stable complex; in the microsomal fraction they behave as peripheral membrane proteins on the cytosolic leaflet; immunoisolation shows enrichment of Rap1, Rab5, and caveolin-1 in tuberin-bound vesicle fractions.\",\n      \"method\": \"Subcellular fractionation, co-immunoprecipitation, magnetic bead immunoisolation, carbonate extraction\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple fractionation approaches with co-IP, single lab, no direct functional consequence demonstrated\",\n      \"pmids\": [\"12147258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pam (a RING-zinc finger protein) associates with the tuberin-hamartin complex in the brain; the C-terminus of Pam (RING domain) binds tuberin; Pam co-localizes with tuberin and hamartin in neurites and growth cones. The Drosophila ortholog HIW genetically interacts with the Tsc1-Tsc2 complex and could negatively regulate its activity.\",\n      \"method\": \"Co-immunoprecipitation, co-localization (immunofluorescence), Drosophila genetic interaction\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP, genetic interaction in Drosophila, no direct functional assay on hamartin specifically\",\n      \"pmids\": [\"14559897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"VPS34 forms a protein complex with PIKFYVE and TSC1 at the plasma membrane via PI3P; this disengages TSC2 from the TSC1/TSC2 heterodimer, leading to TSC2 ubiquitination and degradation, thereby activating RheB and mTORC1/S6K1.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, lipid kinase assay, VPS34 kinase-dead mutant\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with complex components, ubiquitination assay, kinase-dead mutant validation, single lab\",\n      \"pmids\": [\"27409169\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TSC1 (hamartin) forms a heterodimeric complex with TSC2 (tuberin) via coiled-coil interactions; within this complex, TSC2 provides GAP activity toward the small GTPase Rheb, converting it to the inactive GDP-bound form and thereby suppressing mTORC1-mediated cell growth and protein synthesis. TSC1 stabilizes TSC2 by blocking HERC1-mediated ubiquitination, protects the complex from degradation, and recruits it to the lysosomal membrane via its N-terminal HEAT-repeat domain binding to PI3,5P2, enabling starvation-induced mTORC1 inactivation. Beyond this canonical mTORC1-regulatory role, TSC1 acts independently of TSC2 to regulate TGF-β-Smad2/3 signaling, tight junction formation (via myosin-6 and perijunctional actin anchoring), macrophage polarization through a Ras-Raf1-MEK-ERK pathway, and cell adhesion through ERM proteins and Rho/Rac1 GTPase regulation; it is also phosphorylated by CDK1 at G2/M and by IKKβ on Ser487/Ser511, which modulate complex function and link inflammatory signals to mTOR activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TSC1 (hamartin) is a tumor-suppressor protein that, in complex with TSC2 (tuberin), functions as the central negative regulator of mTORC1-driven cell growth and protein synthesis [#0, #9]. TSC1 and TSC2 associate directly through coiled-coil interactions, and patient-derived mutations in the binding interface abolish this association, linking complex integrity to disease [#1, #6]. Within the heterodimer, TSC2 supplies GTPase-activating activity toward the small GTPase Rheb, converting it to its inactive GDP-bound form to suppress mTORC1 and downstream S6K/4E-BP1 signaling [#9]. TSC1 contributes essential regulatory functions: its N-terminal HEAT-repeat domain binds lysosomal phosphoinositides, particularly PI(3,5)P2, to recruit the complex to the lysosome for starvation-induced mTORC1 inactivation, a central helical domain mediates oligomerization, and the C-terminal coiled-coil engages TSC2 [#23]. TSC1 stabilizes TSC2 by binding it and excluding the HERC1 E3 ubiquitin ligase, preventing TSC2 ubiquitination and degradation [#4, #15]. This stabilization is reversed by signals that dismantle the complex: IKKβ phosphorylates TSC1 at Ser487/Ser511 to suppress its function and activate mTOR-driven angiogenesis and tumor growth [#18], and a VPS34–PIKFYVE complex at the plasma membrane disengages TSC2 from TSC1 to drive its degradation and Rheb/mTORC1 activation [#30]. Beyond mTORC1 control, TSC1 acts independently of TSC2 to regulate cytoskeletal and signaling programs: it binds ERM proteins to activate Rho and promote stress fibers and focal adhesions [#3], anchors the perijunctional actin cytoskeleton to β-catenin and ZO-1 via myosin 6 to enable tight junction formation in epithelia [#24], restrains M1 macrophage polarization through a Ras–Raf1–MEK–ERK pathway [#21], and participates in TGF-β–Smad2/3 signaling by associating with the receptor complex and Smads to control growth arrest and EMT [#22]. Through its mTORC1-regulatory and cytoskeletal roles, TSC1 governs diverse physiological outputs including autophagy-mediated neuronal protection from ischemia [#27], osteocyte sclerostin secretion [#25], and osteoclast podosome assembly [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing TSC1 as a tumor suppressor defined the disease relevance and set the stage for mechanistic dissection of its growth-suppressive function.\",\n      \"evidence\": \"Positional cloning with LOH analysis in TSC-associated renal carcinoma\",\n      \"pmids\": [\"9242607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of the encoded protein not yet defined\", \"No binding partners or pathway identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating a direct hamartin-tuberin physical interaction via coiled-coil domains established that the two TSC gene products act as one complex rather than in parallel.\",\n      \"evidence\": \"Co-immunoprecipitation, yeast two-hybrid, and domain mapping\",\n      \"pmids\": [\"9580671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical activity of the complex unknown\", \"Downstream effectors not identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showing hamartin localizes to membrane/particulate fractions independently of tuberin indicated TSC1 has subcellular targeting functions distinct from complex formation.\",\n      \"evidence\": \"Subcellular fractionation and immunofluorescence in tuberin-null Eker rat cells\",\n      \"pmids\": [\"9809973\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the membrane compartment unresolved\", \"Lipid- or protein-binding basis of localization unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linking hamartin to ERM proteins and Rho activation revealed a TSC1 role in actin/adhesion regulation separable from canonical growth suppression.\",\n      \"evidence\": \"Co-IP, dominant-negative inhibition, Rho activity and actin/focal adhesion assays\",\n      \"pmids\": [\"10806479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship to mTOR pathway not addressed\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that hamartin stabilizes tuberin by preventing its ubiquitination explained how TSC1 loss destabilizes the whole complex.\",\n      \"evidence\": \"Co-transfection, ubiquitination assay, pulse-chase\",\n      \"pmids\": [\"11175345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the responsible E3 ligase not yet known\", \"Mechanism of protection (steric vs. competitive) unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Fine-mapping the interaction interface and showing disease mutations disrupt binding connected complex integrity directly to TSC pathology.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, and pathological mutation analysis\",\n      \"pmids\": [\"11741833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the interface not resolved at this stage\", \"Effect on downstream signaling not measured\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying the TSC1-TSC2 complex as a Rheb GAP placed TSC1 at the heart of nutrient/mTOR signaling and unified its growth-suppressive role.\",\n      \"evidence\": \"In vitro GAP assay, epistasis, S6K1 readout, rapamycin sensitivity, patient mutants\",\n      \"pmids\": [\"12906785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TSC1's precise contribution to GAP activity vs. TSC2 not dissected\", \"Spatial regulation of GAP function unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connecting the complex to GSK3β/Axin and β-catenin degradation extended TSC1/TSC2 influence to Wnt signaling.\",\n      \"evidence\": \"Co-IP, luciferase reporter, β-catenin half-life measurement\",\n      \"pmids\": [\"12511557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect role of TSC1 in the degradation complex unclear\", \"In vivo significance not established\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying CDK1-mediated phosphorylation of hamartin at G2/M sites established cell-cycle kinase control of complex activity.\",\n      \"evidence\": \"In vitro kinase assay, cell-cycle synchronization, site-directed mutagenesis, S6K readout\",\n      \"pmids\": [\"14551205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequence of phosphorylation in vivo not defined\", \"Whether phosphorylation alters localization not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing TSC1 excludes the HERC1 E3 ligase from TSC2 provided the molecular mechanism for TSC1-dependent stabilization of tuberin.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitination assay, patient TSC2 mutant analysis\",\n      \"pmids\": [\"16464865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of HERC1 access under physiological signals unknown\", \"Structural mode of exclusion not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Distinguishing opposite effects of TSC1/TSC2 on mTORC1 versus mTORC2 refined the complex's role in two distinct mTOR outputs.\",\n      \"evidence\": \"Knockdown/overexpression in Drosophila S2 and HEK293 cells, S6K and Akt readouts\",\n      \"pmids\": [\"16627617\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of TORC2 activation by the complex unknown\", \"TSC1-specific contribution not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying IKKβ phosphorylation of TSC1 at Ser487/Ser511 linked inflammatory signaling to mTOR activation and tumor angiogenesis.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay, site mutagenesis, tumor IHC and angiogenesis assays\",\n      \"pmids\": [\"17693255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation mechanistically suppresses TSC1 (degradation vs. dissociation) not fully resolved\", \"Reversal/phosphatase not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating mTOR-independent control of M1 macrophage polarization through Ras-Raf1-MEK-ERK established a genuinely TSC2/mTOR-independent TSC1 function.\",\n      \"evidence\": \"Myeloid-specific Tsc1 knockout mice, rapamycin and mTOR deletion, ERK pathway analysis\",\n      \"pmids\": [\"25175012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link between TSC1 and Ras-Raf1 unresolved\", \"Whether TSC1 acts as scaffold or enzyme here unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing TSC1 acts independently of TSC2 within the TGF-β-Smad2/3 pathway broadened its signaling repertoire beyond mTOR.\",\n      \"evidence\": \"Co-IP with receptor complex and Smads, Smad phosphorylation, EMT and target gene assays\",\n      \"pmids\": [\"25727005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TSC1-Smad/receptor binding unknown\", \"How TSC1 partitions between TSC2-dependent and -independent pools unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defining TSC1's three-domain architecture and PI(3,5)P2-dependent lysosomal recruitment revealed how TSC1 spatially targets the complex for starvation-induced mTORC1 inactivation.\",\n      \"evidence\": \"Domain mapping, PIP lipid-binding assay, lysosomal recruitment and mTORC1 activity assays, conservation analysis\",\n      \"pmids\": [\"33974911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of PI(3,5)P2 levels controlling recruitment not detailed\", \"Dynamics of recruitment under fed vs. starved states not fully kinetically resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating TSC1 translocation to cell junctions and myosin-6-dependent anchoring of perijunctional actin established a structural, mTORC1-independent role in epithelial barrier integrity.\",\n      \"evidence\": \"Live-cell imaging, Co-IP of myosin 6/β-catenin/ZO-1, intestine- and skin-specific knockout mice, patient tissue\",\n      \"pmids\": [\"34301883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal triggering TSC1 junctional translocation unknown\", \"Relationship between junctional and lysosomal TSC1 pools unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TSC1 is partitioned among its distinct functional pools — lysosomal TSC2-bound GAP complex, junctional cytoskeletal anchor, and TSC2-independent signaling scaffold — and what governs switching between them remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of TSC1 pool allocation\", \"Upstream determinants directing TSC1 to TSC2-independent functions unknown\", \"Structural details of TSC1's TSC2-independent complexes lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 4, 15]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [24, 22]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [3, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [28, 2]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [30, 24]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [3, 24, 28]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-165159\", \"supporting_discovery_ids\": [9, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 18, 22, 21]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [27]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 18]}\n    ],\n    \"complexes\": [\n      \"TSC1-TSC2 (hamartin-tuberin) complex\",\n      \"VPS34-PIKFYVE-TSC1 complex\"\n    ],\n    \"partners\": [\n      \"TSC2\",\n      \"RHEB\",\n      \"HERC1\",\n      \"IKBKB\",\n      \"EZR\",\n      \"MYO6\",\n      \"SMAD2\",\n      \"PLK1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}